The Center for Peripartum Optimization

NCT03522909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-09-13

No results posted yet for this study

Summary

In January 2017 investigators started a Center for Peripartum Optimization (CPO) with the aim of optimizing a patient's clinical status in an outpatient setting to minimize unnecessary laboratory tests and studies, costly inpatient consultations, the likelihood of post-surgical adverse events, escalations in level of care, inpatient admissions and readmissions. This research project seeks to evaluate the impact of this innovative concept on patient outcomes during the last 12 months. Investigators will accomplish this by collecting retrospective data from patients' electronic medical records in the intervention group and comparing it to data gathered from a controlled group of patients with similar comorbidities but who were not evaluated at the CPO clinic.

Conditions

  • High Risk Pregnancy
  • Multidisciplinary Communication
  • Communication
  • Obstetric Complication

Interventions

OTHER

Seen in clinic

We will be doing a retrospective chart review of patients seen in the Center for Peripartum Optimization to look for: 1. Primary outcome variable. \- Hospital length of stay 2. Secondary outcome variables. * Number of admissions from outside hospitals * Adverse outcomes * Intensive Care Unit admissions * Opioid use * NICU admissions * Patient satisfaction * Cost of inpatient admission * Cost of outpatient care * Hospital readmissions rate

Sponsors & Collaborators

Principal Investigators

  • Jamie D Murphy, MD · Johns Hopkins University

Eligibility

Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03522909 on ClinicalTrials.gov